Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 4NIH 2NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other neoplasm 2Gynecologic 1

Conditions

Precancerous Conditions 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Papillomavirus Infections 1

Interventions

Cyclophosphamide 178Radiotherapy 147Paclitaxel 128Carboplatin 124Bevacizumab 123Cisplatin 119Doxorubicin 111Fluorouracil 107Etoposide 102Filgrastim 99Vincristine 88Leucovorin 82Bortezomib 80Gemcitabine 76aldesleukin 74Sorafenib 70Cytarabine 70Taxes 69fludarabine phosphate 67Irinotecan 66Docetaxel 64Oxaliplatin 60sargramostim 58Sirolimus 58temsirolimus 56Erlotinib Hydrochloride 56Methotrexate 55Rituximab 54Vorinostat 52Radiation 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × NIH × Vaginal Smears × Clear all
NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00977392 2013-08-07

Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening

National Cancer Institute (NCI)

Completed
3,000 enrolled
Other neoplasm

Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡